
The Bush administration settles class action lawsuit, pledging major improvements in the Medicare Part D prescription drug program.

The Bush administration settles class action lawsuit, pledging major improvements in the Medicare Part D prescription drug program.

HR 6331 narrowly fails to get the support it needs in the Senate.

Additionally, 2 new combination vaccines could make following CDC's immunization recommendations easier by reducing the number of shots children must receive.

A new study is showing patients the money by offering a chance to win cash for taking medication.

A new study demonstrates that pharmacist intervention and home monitoring of BP can help patients manage their condition.

Intravenous bisphosphonates, often used to treat metastases and bone pain in breast cancer patients, are now being used by clinicians for osteoporosis in these patients—pharmacists need to recommend appropriate screening and treatment.



Ms. Terrie is a clinical pharmacy writer based in Haymarket, Va.

Dr. Pelegrin is a pharmacy manager with Publix Supermarkets in Miami, Fla, and an associate clinical professor at the University of Florida, Gainesville.

Dr. Pino is an assistant professor of pharmacy practice at Lloyd L. Gregory School of Pharmacy, Palm Beach Atlantic University, West Palm Beach, Fla.

Dr. Zanni is a psychologist and health-systems consultant based in Alexandria, Va.

Ms. Wick is a senior clinical research pharmacist at the National Cancer Institute, National Institutes of Health, Bethesda, Md. The views expressed are those of the author and not those of any government agency.

















Key Finding #3 - How Well Informed Do You Think You are About OTC Cold and Flu Products? As promised in the first newsletter, the third of five audio podcasts is now available at http://www.pharmacytimes.com/cold-and-flu and www.Zicam.com. • The survey showed that only 37 percent of pharmacists say they actively search out information about OTC cold and flu products. Despite expectations for more questions about this category, only 30 percent of pharmacists feel very well-informed about OTC cold and flu products. o Further, almost half of pharmacists do not feel familiar with any of the recent FDA actions affecting non-prescription drugs this past summer. • Dr. Eckel and other roundtable attendees acknowledged these results and confirmed that there is an overabundance of information sent to pharmacists, including label updates and formulation changes, which has confused pharmacists, specifically around OTC medications, proving that there is a need for more easy-to-understand, easy-to-access information. • Stay tuned for next week’s podcast which will discuss the importance of treating a cold early.